Search

everythinglearnresearchcommunity

for

Search:↓

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Spironolactone most effective for hirsutism, but has side effects.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Flutamide reduces hair growth better but has more side effects.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.